Selecting Multitarget Peptides for Alzheimer's Disease.

Kasus-Jacobi, Anne; Washburn, Jennifer L; Laurence, Riley B; Pereira, H Anne

Kasus-Jacobi, Anne; Washburn, Jennifer L; Laurence, Riley B; Pereira, H Anne.

Afiliação

Kasus-Jacobi A; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Washburn JL; Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Laurence RB; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Pereira HA; Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.

Biomolecules ; 12(10)2022 09 27.

Article em En | MEDLINE | ID: mdl-36291595

Assuntos

Doença de Alzheimer; Animais; Camundongos; Humanos; Doença de Alzheimer/tratamento farmacológico; Doença de Alzheimer/metabolismo; Peptídeos beta-Amiloides/metabolismo; Receptor 4 Toll-Like/metabolismo; Receptor para Produtos Finais de Glicação Avançada/metabolismo; Catepsina G/metabolismo; Azul Tripano; Proteínas de Ligação ao Cálcio

Palavras-chave

Alzheimer's disease; S100 calcium-binding protein A9; Toll-like receptor 4; amyloid beta; cathepsin G; multitarget drug; neurodegeneration; neuroinflammation; neutrophil; receptor for advanced glycation end-products

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google